Aptose Biosciences Inc.

Informe acción TSX:APS

Capitalización de mercado: CA$24.2m

Salud financiera de hoja de balance de Aptose Biosciences

Salud financiera controles de criterios 5/6

Aptose Biosciences tiene un patrimonio de los accionistas total de $137.0K y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $12.8M y $12.7M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$9.33m
PatrimonioUS$137.00k
Total pasivoUS$12.66m
Activos totalesUS$12.80m

Actualizaciones recientes sobre salud financiera

Here's Why We're Watching Aptose Biosciences' (TSE:APS) Cash Burn Situation

Mar 26
Here's Why We're Watching Aptose Biosciences' (TSE:APS) Cash Burn Situation

We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate

Dec 08
We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate

We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate

Aug 05
We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate

Recent updates

Here's Why We're Watching Aptose Biosciences' (TSE:APS) Cash Burn Situation

Mar 26
Here's Why We're Watching Aptose Biosciences' (TSE:APS) Cash Burn Situation

We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate

Dec 08
We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate

We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate

Aug 05
We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate

We Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth Carefully

Apr 02
We Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth Carefully

Companies Like Aptose Biosciences (TSE:APS) Are In A Position To Invest In Growth

Sep 30
Companies Like Aptose Biosciences (TSE:APS) Are In A Position To Invest In Growth

Aptose Biosciences Inc. (TSE:APS) Insiders Have Been Selling

Feb 07
Aptose Biosciences Inc. (TSE:APS) Insiders Have Been Selling

Is Aptose Biosciences Inc.'s (TSE:APS) Shareholder Ownership Skewed Towards Insiders?

Jan 03
Is Aptose Biosciences Inc.'s (TSE:APS) Shareholder Ownership Skewed Towards Insiders?

We're Not Very Worried About Aptose Biosciences' (TSE:APS) Cash Burn Rate

Nov 29
We're Not Very Worried About Aptose Biosciences' (TSE:APS) Cash Burn Rate

Jotin Marango Is The Senior VP & Chief Business Officer of Aptose Biosciences Inc. (TSE:APS) And They Just Sold 26% Of Their Shares

Jul 11
Jotin Marango Is The Senior VP & Chief Business Officer of Aptose Biosciences Inc. (TSE:APS) And They Just Sold 26% Of Their Shares

Aptose Biosciences Inc. (TSE:APS) Insiders Have Been Selling

Jun 27
Aptose Biosciences Inc. (TSE:APS) Insiders Have Been Selling

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($11.8M) de APS no cubren sus pasivos a corto plazo ($12.1M).

Pasivo a largo plazo: Los activos a corto plazo de APS ($11.8M) superan a sus pasivos a largo plazo ($520.0K).


Historial y análisis de deuda-patrimonio

Nivel de deuda: APS está libre de deudas.

Reducción de la deuda: APS no tenía deudas hace 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: APS tiene suficiente cash runway para 2 meses según el flujo de caja libre último declarado, pero desde entonces ha obtenido capital adicional.

Pronóstico de cash runway: Se prevé que APS disponga de suficiente cash runway para 2 meses según las estimaciones de flujo de caja libre, aunque ha obtenido desde entonces capital adicional.


Descubre empresas con salud financiera